Addictions, Drug & Alcohol Institute
Addictions, Drug & Alcohol Institute > ADAI Publications

ADAI Publications

1331 publications found

  1. Hatch MA, Laschober TC, Ertl MM, Paschen-Wolff MM, Norman G, Wright L, Tross S. Program director reports of COVID-19 lockdown-driven service changes in community-based STI clinics and syringe services programs in the southeastern U.S. AIDS Education and Prevention 2024;36(2):129-40. [doi: 10.1521/aeap.2024.36.2.129] PMID: 38648174 PMCID: PMC11608127
  2. Carlini BH, Harwick RH, Williams JR. Language Matters: Cannabis and Tobacco Use Among Youth of Diverse Racial/Ethnic Backgrounds. Seattle, WA: Addictions, Drug & Alcohol Institute, Department of Psychiatry & Behavioral Sciences, School of Medicine, University of Washington, July 2024.
  3. Carlini BH, Garrett SB, Matos P, Nims LN, Kestens Y. Identifying policy options to regulate high potency cannabis: A multiple stakeholder concept mapping study in Washington State, USA. International Journal of Drug Policy 2024;123:104270. [doi: 10.1016/j.drugpo.2023.104270] PMID: 38043404
  4. Khan Z, Harris JR, Dearden L, Strait M, Treend K, Glesmann H, Carlini BH. Trends in varenicline use for tobacco cessation, and their implications. Journal of the American Pharmacists Association 2024;64(4):102102. [doi: 10.1016/j.japh.2024.102102] PMID: 38649095
  5. Torres VN, Williams EC, Ceballos RM, Donovan DM, Ornelas IJ. Discrimination, acculturative stress, alcohol use and their associations with alcohol-related consequences among Latino immigrant men. Journal of Ethnicity in Substance Abuse 2024;23(1):150-165. [doi: 10.1080/15332640.2022.2077273] PMID: 35634786
  6. Petersky S, Banta-Green CJ. Results from the 2024 WA State Permanent Supportive Housing Perceptions and Community Health Survey. Seattle, WA: Addictions, Drug & Alcohol Institute, Department of Psychiatry & Behavioral Sciences, School of Medicine, University of Washington, September 2024
  7. Owens MD, McKee M, Rickert C, Rogel B, Starnes B. Development and exploratory evaluation of substance use and substance use disorder training for the Washington State Basic Law Enforcement Academy. Policing 2024;18:paae091. [doi: 10.1093/police/paae091]
  8. Banta-Green CJ, Owens MD, Williams JR, Floyd AS, Williams-Gilbert W, Kingston S. Community-based medications first for opioid use disorder – Care utilization and mortality outcomes. Substance Abuse and Rehabilitation 2024;15:173-183 [doi: 10.2147/sar.s475807]
  9. Harwick RM, Carlini BH, Williams JR. Food hardship as a strong predictor of tobacco and cannabis use among youth in WA state. Children and Youth Services Review 2024;157:107427. [doi: 10.1016/j.childyouth.2023.107427]
  10. Nelson LA, Shinagawa E, Garza CM, Squetimkni-Anquoe A, Jeffries I, Rajeez V, Taylor EM, Taylor S, Eakins D, Parker ME, Ubay T, King V, Duffing-Romero X, Park S, Saplan S, Clifasefi SL, Lowe J, Collins SE. A pilot study of virtual Harm Reduction Talking Circles for American Indian and Alaska Native adults with alcohol use disorder. Journal of Community Psychology 2024;52(6):739-761. [doi: 10.1002/jcop.23127] PMID: 38932516
  11. UW Center for Community-Engaged Drug Education, Epidemiology & Research (CEDEER), Banta-Green CJ. Washington State Drug Brief: BTMPS – A New Substance Found in Community Drug Checking Samples. Seattle, WA: Addictions, Drug & Alcohol Institute, Department of Psychiatry & Behavioral Sciences, School of Medicine, University of Washington, September 2024
  12. Winstead T, Singh S, Floyd A, Banta-Green C. Contingency Management for Methamphetamine Use: Qualitative Interviews at Harm Reduction Programs. Seattle, WA: Addictions, Drug & Alcohol Institute, Department of Psychiatry & Behavioral Sciences, School of Medicine, University of Washington, March 2024
  13. Green TC, Silcox J, Boliver D, Gray M, Floyd AS, Irwin AN, Hansen RN, Hartung DM, Bratberg J. Pharmacy staff-reported adaptations to naloxone provision and over-the-counter (OTC) syringe sales during the COVID-19 pandemic: Experiences across multiple states and 2 pharmacy chains. Journal of the American Pharmacists Association 2024;64(1):71-78. [doi: 10.1016/j.japh.2023.10.014] PMID: 37863398 PMCID: PMC11014459
  14. Carlini BH, Kellum LB, Garrett SB, Nims LN. Threaten, distract, and discredit: Cannabis industry rhetoric to defeat regulation of high-THC cannabis products in Washington State, USA. Journal of Studies on Alcohol and Drugs 2024;85(3):322-329. [doi: 10.15288/jsad.23-00277] PMID: 38270913 PMCID: PMC11218453
  15. LoParco CR, Cui Y, McCready D, Romm KF, Yang TY, Rossheim ME, Carlini B, Vinson K, Cavazos-Rehg P, Berg CJ. State requirements for non-medical US cannabis retail personnel. Journal of Public Health Management and Practice 2024;30(4):517-525. [doi: 10.1097/PHH.0000000000001892] PMID: 38833682
  16. Frank ND, Banta-Green CJ, Guthrie BL, Kingston S, Tinsley J, Whiteside L, Glick SN. Emergency room utilization and methamphetamine overdose symptoms among syringe services program participants in Washington State. Substance Use & Misuse 2024;59(7):1012-1019. [doi: 10.1080/10826084.2024.2317148] PMID: 38369494
  17. Heidari O, Banta-Green CJ. Expanding access to medications for opioid use disorder: Federal policy is only a part of the solution [editorial]. American Journal of Public Health 2024;114(7):693-695. [doi: 10.2105/AJPH.2024.307715] PMID: 38838294 PMCID: PMC11153965
  18. Douaihy A, Donovan DM, Daley DC. Twelve-step facilitation approaches. IN: Miller SC, Rosenthal RN, Levy S, Saxon AJ, Tetrault JM, Wakeman SE (eds.). THE ASAM PRINCIPLES OF ADDICTION MEDICINE (7th edition). Philadelphia: Wolters Kluwer, p. 1213-1218
  19. Allen JA, Benowitz N, Blumenthal R, Carlini BH, Cooper Z, Fong T, Halpern-Felsher B, Johnson RM, Ling P, Pacula R, Piomelli D, Silver LD, Young-Wolff K. Report and Recommendations of the High Potency Cannabis Think Tank to the State of California. Sacramento, CA: California Department of Public Health, October 2024, 42p.
  20. Irwin AN, Gray M, Ventricelli D, Boggis JS, Bratberg J, Floyd AS, Silcox J, Hartung DM, Green TC. “I go out of my way to give them an extra smile now:” A study of pharmacists who participated in Respond to Prevent, a community pharmacy intervention to accelerate provision of harm reduction materials. Research in Social and Administrative Pharmacy 2024;20(5):512-519. [doi: 10.1016/j.sapharm.2024.02.001] PMID: 38395644 PMCID: PMC10981567
  21. Blough MJ, Rocha A, Bratberg J, Silcox J, Bolivar D, Floyd AS, Gray M, Green TC. The cost of safe injection: Insights on nonprescription syringe price variability from systematic secret shopping. Substance Use & Addiction Journal 2024;45(2):201-210. [doi: 10.1177/29767342231217831] PMID: 38258818
  22. Douaihy A, Daley DC, Donovan DM. Relapse prevention: Clinical models and intervention strategies. IN: Miller SC, Rosenthal RN, Levy S, Saxon AJ, Tetrault JM, Wakeman SE (eds.). THE ASAM PRINCIPLES OF ADDICTION MEDICINE (7th edition). Philadelphia: Wolters Kluwer, p. 1219-1235
  23. Carpenter KM, Walker DD, Mullis K, Berlin HM, Short E, Javitz HS, Carlini BH. Testing a brief quitline intervention for tobacco cannabis co-users: A randomized controlled pilot study. Tobacco Use Insights 2024;17:117917x241261302. [doi: 10.1177/1179173X241261302] PMID: 38873657 PMCID: PMC11171437
  24. Hatch MA, Laschober TC, Paschen-Wolff M, Ertl MM, Nelson CM, Wright L, Lancaster C, Feaster DJ, Forrest D, Hankey C, Monger M, Fegley JP, Irving R, Young C, Rose J, Spector A, Dresser L, Moran L, Jelstrom E, Tross S. PrEP for people who use opioids: A NIDA Clinical Trials Network survey study in Southern U.S. cities where HIV incidence is high. Drug and Alcohol Dependence 2024;257:111133. [doi: 10.1016/j.drugalcdep.2024.111133] PMID: 38447393 PMCID: PMC11131129
  25. Floyd AS, Silcox J, Strickler G, Nong T, Blough M, Bolivar D, Rabin M, Bratberg J, Irwin AN, Hartung DM, Hansen RN, Bohler R, Green TC. Policies, adaptations, and ongoing challenges to naloxone, buprenorphine and nonprescription syringe access across four-states: Findings from an environmental scan and key informant interviews. Drug and Alcohol Dependence Rep 2024;11:100243. [doi: 10.1016/j.dadr.2024.100243]
  26. Pusnik A, Hartzler B, Vjorn O, Rutkowski BA, Chaple M, Becker S, Freese T, Nichols M, Molfenter T. Comparison of use rates of telehealth services for substance use disorder during and following COVID-19 safety distancing recommendations: Two cross-sectional surveys. JMIR Mental Health 2024;11:e52363. [doi: 10.2196/52363] PMID: 39136186 PMCID: PMC11331268
  27. Fockele CE, Morse SC, van Draanen J, Leyde S, Banta-Green C, Huynh LN, Zatzick A, Whiteside LK. “That line that just kept moving”: Motivations and experiences of people who use methamphetamine. West J Emerg Med 2023;24(2):218-227. [doi: 10.5811/westjem.2022.12.58396] PMID: 36976607 PMCID: PMC10047723
  28. Carlini B, Garrett S, Kellum L, Nims L. Cannabis Research Report, 2021-2023. Seattle, WA: Addictions, Drug & Alcohol Institute, Department of Psychiatry & Behavioral Sciences, School of Medicine, University of Washington, August 2023
  29. Kingston S, Biamont B, Banta-Green C. Community Drug Checking Network. The Use and Impact of Community Drug Checking Services. Seattle, WA: Addictions, Drug & Alcohol Institute, Department of Psychiatry & Behavioral Sciences, School of Medicine, University of Washington, November 2023
  30. Hall W, Leung J, Carlini BH. Do not let the ideal be the enemy of good enough regulation [commentary]. Addiction 2023;118(6):1009-1010. [doi: 10.1111/add.16201]
  31. Irwin AN, Bratberg J, Al-Jammali Z, Arnold J, Gray M, Floyd AS, Boliver D, Hansen R, Hartun DM, Green TC. Implementation of an academic detailing intervention to increase naloxone distribution and foster engagement in harm reduction from the community clinician. Journal of the American Pharmacists Association 2023;63(1):284-294.e1. [doi: 10.1016/j.japh.2022.12.001] PMID: 36567216 PMCID: PMC9933140
  32. Owens MD, Banta-Green CJ, Newman A, Marren R, Takushi R. Insights into a recovery community center model: Results from qualitative interviews with staff and member facilitators from Recovery Cafe in Seattle, Washington. Alcoholism Treatment Quarterly 2023; 41(1):62-75. [doi: 10.1080/07347324.2022.2088323]
  33. Stoner SA, Graham JC, Grant TM. Evaluating outcomes of a three-year case management program for mothers with prenatal substance use according to race/ethnicity, Washington State, 2006–2017. BMC Public Health 2023;23:1832. [doi: 10.1186/s12889-023-16670-z] PMID: 37730578 PMCID: PMC10512570
  34. Boyle HK, Singh S, Lopez G, Jackson KM, Carey KB, Merrill JE. Insights into the context of simultaneous alcohol and cannabis use among young adults. Experimental and Clinical Psychopharmacology 2023;31(3):662-673. [doi: 10.1037/pha0000607] PMID: 36174141 PMCID: PMC10201978
  35. Salow K, Jack HE, Tinsley J, Banta-Green CJ, Kingston S, Iles-Shih M, Tsui J, Glick S. Racial disparities in use of syringe service programs in King County, WA: A comparison of two cross-sectional surveys. Harm Reduction Journal 2023;20:133. [doi: 10.1186/s12954-023-00868-w] PMID: 37704989 PMCID: PMC10500904
  36. Trinidad SB, Shane AL, Guinn TR, Apok CR, Collier AF, Avey JP, Donovan DM. Cultural adaptation of a sobriety support app for Alaska Native and American Indian people: A qualitative study. JMIR Formative Research 2023;7:e38894. [doi: 10.2196/38894] PMID: 36473107 PMCID: PMC9944154
  37. Hancock C, Johnson A, Sladky M, Chen LL, Shushan S, Parchman ML. Integrating MOUD and primary care: Outcomes of a multicenter learning collaborative. Family Medicine 2023;55(7):452-459. [doi: 10.22454/FamMed.2023.643371] PMID: 37450845 PMCID: PMC10622073
  38. Dillard DA, Hebert LE, Shaw JL, Trinidad SB, Dirks LG, Lillie K, Ludman EJ, Donovan D, Burke W. Measuring attitudes about alcohol misuse and dependence among Alaska Native people within a tribal health care system. Journal of Addiction Medicine 2023;17(1):e42-e48. [doi: 10.1097/ADM.0000000000001040] PMID: 36166685
  39. Hartzler B, Gray K, Marx M, Kirk-Lewis K, Payne-Smith K, McIlveen JW. Community implementation of contingency management to address stimulant use. Journal of Substance Use and Addiction Treatment 2023;151:208941. [doi: 10.1016/j.josat.2022.208941]
  40. Park CJ, Freeman LK, Hall NA, Singh S, Carey KB, Merrill JE, DiBello AM, Miller MB. Gender, acculturation, and alcohol-related consequences among college students of color. Journal of American College Health 2023;71(1):44-52. [doi: 10.1080/07448481.2021.1891079] PMID: 33651663 PMCID: PMC8410888
  41. Banta-Green CJ, Owens MD, Williams JR, Sears JM, Floyd AS, Williams-Gilbert W, Kingston S. Community Based Medications First for Opioid Use Disorder – Care Utilization and Mortality Outcomes. Poster presented at the College on Problems of Drug Dependence (CPDD) annual meeting, Denver, CO, June 2023
  42. Eakins D, Gaffney A, Marum C, Wangmo T, Parker M, Magarati M. Indigenous Evaluation Toolkit: An Actionable Guide for Organizations Serving American Indian/Alaska Native Communities through Opioid Prevention Programming. Seattle, WA: Seven Directions, University of Washington, February 2023, 126 p.
  43. Washington State Health Care Authority, University of Washington Addictions, Drug & Alcohol Institute [Carlini BH, Garrett SB, Nims LN].. High THC Policy | Final Report: Exploring Policy Solutions to Address Public Health Challenges of High THC Products. Engrossed Substitute Senate Bill 5092; Section 215(55); Chapter 334; Laws of 2021. Olympia, WA; Washington State Health Care Authority, December 2022
  44. ADAI, Research with Expert Advisors on Drug Use (READU) Team, Owens M. Summary of Findings – Policy Codesign to Improve Interactions Between Law Enforcementa and People Who Use Drugs. Seattle, WA: Addictions, Drug & Alcohol Institute, Department of Psychiatry & Behavioral Sciences, School of Medicine, University of Washington, June 2023, 21 p.
  45. Hartzler B, Hinde J, Lang S, Correia N, Yermash J, Yap K, Murphy CM, Ruwala R, Rash CJ, Becker SJ, Garner BR. Virtual training is more cost-effective than in-person training for preparing staff to implement contingency management. Journal of Technology in Behavioral Science 2023;8:255-264. [doi: 10.1007/s41347-022-00283-1] PMID: 36246531 PMCID: PMC9553630
  46. Boyle HK, Singh S, Lopez G, Carey KB, Jackson KM, Merrill JE. A qualitative examination of positive and negative consequences young adults experience from simultaneous alcohol and cannabis use. Psychology of Addictive Behaviors 2023;37(4):639-650. [doi: 10.1037/adb0000886] PMID: 36301269 PMCID: PMC10133411
  47. Hall W, Leung J, Carlini BH. How should policy makers regulate the tetrahydrocannabinol content of cannabis products in a legal market? [opinion]. Addiction 2023;118(6):998-1003. [doi: 10.1111/add.16135]
  48. Jirkowic T, Graham CJ, Grant T. A trauma-informed parenting intervention model for mothers parenting young children during residential treatment for substance use disorder. Occupational Therapy in Mental Health 2023;39(2):156-183. [doi:10.1080/0164212X.2022.2089315]
  49. Boyle HK, Singh S, Lopez G, Carey KB, Jackson KM, Merrill JE. A qualitative examination of the decision-making process of simultaneous alcohol and cannabis use: Intentions and willingness. Alcohol: Clinical & Experimental Research 2023;47(1):168-179. [doi: 10.1111/acer.14982] PMID: 36480451 PMCID: PMC10275144
  50. McClure EA, Hamilton L, Schauer GL, Matson TE, Lapham GT. Cannabis and nicotine co-use among primary care patients in a state with legal cannabis access. Addictive Behaviors 2023;140:107621. [doi: 10.1016/j.addbeh.2023.107621] PMID: 36706676 PMCID: PMC10854219